Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

July 6, 2021

Study Completion Date

September 7, 2021

Conditions
Uncontrolled GoutKidney Transplant
Interventions
BIOLOGICAL

Pegloticase

intravenous (IV) infusion

Trial Locations (8)

27705

Duke University Medical Center, Durham

31520

Coastal Medical Research, Brunswick

33614

Genesis Clinical Research, Tampa

35294

University of Alabama Birmingham, Birmingham

35805

Nephrology Consultants, Huntsville

77598

Clear Lake Specialties, Webster

90033

Keck School of Medicine of USC, Los Angeles

91324

Amicis Research Center, Northridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY